Author(s):
Jaishri Kaushik, Namita Bharadwaj, Pratyush Jaiswal
Email(s):
kaushik.jaishri08@gmail.com
DOI:
10.52711/0974-360X.2022.00377 
Address:
Dr. Jaishri Kaushik1*, Dr. Namita Bharadwaj2, Pratyush Jaiswal3
1Assistant Professor, Department of Chemistry, LCIT College of Commerce & Science, Bilaspur (C.G.) India.
2Professor, Department of Chemistry, Dr. C.V. Raman University, Kota-495113, Dist-Bilaspur, (C.G.) India.
3Research Scholar, Department of Chemistry, Dr. C.V. Raman University, Kota-495113, Dist-Bilaspur, (C.G.) India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 5,
Year - 2022
ABSTRACT:
The Simple, selective, and expeditious spectrophotometric methods have been developed for the determination of complexation of 4-[(1R)-2-amino-1-hydroxyethyl] benzene-1,2-diol with metal ions in pharmaceutical field. The method was based on complex formation between the antihypotensive drug and transition metal ions in a basic medium (pH 9.2). The colored complexes were measured at 280 nm wavelength for 4-[(1R)-2-amino-1-hydroxyethyl] benzene-1, 2-diol. The different experimental parameters affecting the development and stability of the colour were carefully studied and optimized. The stability constant of complex were calculated to be Ag(?)-4-[(1R)-2-amino-1-hydroxyethyl] benzene-1,2-diol is 4.34, Pd (??)-4-[(1R)-2-amino-1-hydroxyethyl] benzene-1,2-diol is 5.75 & Cd (??) - 4-[(1R)-2-amino-1-hydroxyethyl] benzene-1,2-diol is 3.82 by job’s continuous variation method. The stoichiometry of the complexes formed between the antihypotensive drugs and the metal ions was 1:1 M/L ratio. The proposed method was further applied to the determination of drug in pure and dosage forms. The results obtained were in good agreement with those obtained by a reference to UV–Visible Spectrophotometric method.
Cite this article:
Jaishri Kaushik, Namita Bharadwaj, Pratyush Jaiswal. Study of Stability Constant of Some Transition Metal Complexes Formed With 4-[(1R)-2-amino-1-hydroxyethyl] benzene-1, 2-diol. Research Journal of Pharmacy and Technology. 2022; 15(5):2268-2. doi: 10.52711/0974-360X.2022.00377
Cite(Electronic):
Jaishri Kaushik, Namita Bharadwaj, Pratyush Jaiswal. Study of Stability Constant of Some Transition Metal Complexes Formed With 4-[(1R)-2-amino-1-hydroxyethyl] benzene-1, 2-diol. Research Journal of Pharmacy and Technology. 2022; 15(5):2268-2. doi: 10.52711/0974-360X.2022.00377 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-5-59
REFERENCES:
1. Seku K, Yamala A, Kinchella M. Synthesis of moxifloxacin–Au (III) and Ag (I) metal complexes and their biological activities. Journal of Analytical Science and Technology. 2018; 9(14): 1-13.
2. Ott I. et al. On the medicinal chemistry of gold complexes as anticancer drugs. Coord Chem Rev. 2009; 253(11):1670–1681.
3. Gasser G, Ott I, Metzler-Nolte N. Organometallic anticancer compounds. J Med Chem. 2011; 13(1):3–25
4. Maftei CV et al. N-heterocyclic carbenes (NHC) with 1, 2, 4-oxadiazolesubstituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold (I) and silver (I) complexes. Eur J Med Chem. 2015; 101 (28): 431–44.
5. Simon M, Csunderlik C, Cotarca L, Caproiu MT, Neda I, Turoczi MC, Volpicelli R. Synthesis of new active 0-nitrophenyl carbamates. Synth Commun. 2005; 35(11):1471–1489.
6. Thompson KH, Orvig C. Boon and bane of metal ions in medicine. Science 2003; 300: 936-939.
7. Selvaganapathy M., Raman N. Pharmacological Activity of a Few Transition Metal Complexes: A Short Review. J ChemBiolTher.2016; 1 (2): 1-17.
8. Pedrares AS, Romero J, et al. Electrochemical synthesis and structural characterization of zinc, cadmium and mercury complexes of heterocyclic bidentate ligands (N, S). Dalton Trans (2003): 7: 1379-1388.
9. El-Asmy AA, Khalifa ME, Hassanian MM. Synthesis and characterization of transition metal complexes containing oxime, amido and thioamido groups. Indian J Chem. 2004; 4(3): 92-97.
10. Ekegren JK et al. Synthesis and evaluation of N, S-compounds as chiral ligands for transfer hydrogenation of acetophenone. Org Biomol Chem.2003; 1: 358-366.
11. Masoud MS et al. Journal of Chem. Pharm. Res., 2017; 9(12): 59-76.
12. Hambley TW et al. Science.2007; 318: 1392-1393.
13. DhoteV , Jain P , Jain V . New analytical method development and validation for the estimation of Midodrine HCl by UV and HPLC. Int. J. Res. Dev. Pharm. L . 2018; 7(4): 3060-3070.
14. Ramteke A, Narwade ML. Spectrophotometric Studies on stability constant of chlorosubstitutedpyrazoles with Cu (II) Nd (III) and Tb (III) metal ions at 0.1 M Ionic strength D. 2012; 3(5): 1036-1040.
15. Diduk RA, Galan A. Adrenaline and Noradrenaline: Protectors against Oxidative Stress or Molecular Targets. American Chemical Society J. Phys. Chem. B 2015; 119: 3479−3491.
16. Gülçin, I. Antioxidant activity of L-adrenaline: A structure activity insight. Chem.-Biol. Interact. 2009; 179: 71−80.
17. Cahova, M., Palenickova, E, Papackova, Z, Dankova, H, Skop, V, Kazdova, L. Epinephrine-dependent control of glucose metabolism in white adipose tissue: The role of α- and β-adrenergic signaling. Exp. Biol. Med. 2012; 237: 211−218.
18. Wu J, Ji, M. H, Wang, Z Y, Zhu, W, Yang, J. J, Peng, Y G. Blood pressure reduction induced by low dose of epinephrine via different routes in rats. J. Cardiovasc. Pharmacol. 2013; 62: 325−328.
19. Errasti AE, Werneck De, Avellar, M C, Daray, F M, Tramontano, J, Luciani, L I, Lina M J, Maróstica, E, Rothlin, RP. Human umbilical vein vasoconstriction induced by epinephrine acting on α1b-adrenoceptor subtype. Am. J. Obstet. Gynecol. 2003; 189: 1472−1480.
20. Foote SL, Bloom FE. Aston Jones, G. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiol. Rev. 1983; 63: 844−914.
21. ARUMUGAM et al., Manganese (III) Acetate Mediated Synthesis of 3-arylsulfenylindoles and Evaluation of Their Antibacterial Activity. Orient. J. Chem., 2018; 34(1): 457-466.
22. Funk, C. D et al. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat. Rev. Drug Discovery. 2005; 4(1): 664-672.
23. Armer, R. E.; G. Wynne, M. PCT Int. Appl. WO2008012511, 2008.
24. P.B. Agrawal, Ultra Science. 2006; 18(1): 101-105
25. P. Job’s. Spectrophotometric study of Co (II) – chrome azurol S chelate. Annal. Chem. 1928; 10(9): 113.
26. Alkaya D, Karadari S, Erdogan G. Tersary complex formation of isoniazid with some transition metal and amino acid. J. Nat. Sci. 2013; 14(1): 1 -14.
27. Gaber M, Khedr A, Kady A. Spectrophotometric determination of norfloxacin in pure and dosage form by complexation with Fe (Ⅲ) and Cu (Ⅱ). Int. Res. J. Pharm. Pharmacol . 2012; 2(5) : 97-102.
28. Bharadwaj N, Kaushik J. Comparative analysis of complexation of labetalol and chlorthalidon with Cu (Ⅱ) ion - A Spectrophotometric analysis. Ejpmr. 2017; 4(7): 466-468.
29. Bharadwaj N, Koshle G. Complexation of Norfloxacin with Some Transition Metal Ions - A Spectrophotometric Study. J. Chem and Chem. Sci .2016; 6 (9): 821-825.
30. Bjerrum J et al. Metal Ammine formation in Aqueous Solution, P. Haase and Son, Copenhagen, 1941.
31. Britton HT. Hydrogen Ions, Vol. 1, 2nd Ed. Longman, London. Through personal communication of Egyptian International Pharmaceutical Industries Co, 1952; 16294/1989.
32. Ramteke A, Narwade M. Spectrophotometric Studies on stability constant of chlorosubstituted pyrazoles with Cu (II) Nd (III) and Tb (III) metal ions at 0.1 M Ionic strength. Der Chemica Sinica.2012; 3(5): 1036-1040.
33. Francesco C, Concetta S, Anna I, Gabriele L, Stefano M, Demetrio M, Alberto P, Silvio S. Understanding the Solution Behavior of Epinephrine in the Presence of Toxic Cations: A Thermodynamic Investigation in Different Experimental Conditions. Molecules.2020; 25 (1): 1-26.
34. Rashid AA, Naggar AH, Farghaly OA, Mauof HA, Ekshiba AA. Potentiometric and Conductometric studies of Sulfathiazole: Glycine Binary and Ternary Complexes. Int. J. Electrochem. Sci. 2019; 14: 1132 – 1146.